The trademark application ZYKIMBRI was filed by AbbVie AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on May 31, 2021, and it was registered by office on September 7, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders.